[Preliminary results of treatment of symptomatic and asymptomatic bacteriuria in pregnancy with a new chemotherapeutic agent].
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001437:Bacteriuria / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Primi risultati del trattamento della batteriuria sintomatica ed asintomatica in gravidanza con un nuovo chemioterapico.